Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126232841 | 12623284 | 1 | I | 20160711 | 20160728 | 20160804 | 20160804 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201607012447 | ELI LILLY AND CO | 52.51 | YR | F | Y | 0.00000 | 20160803 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126232841 | 12623284 | 1 | PS | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK UNK, UNKNOWN | 20509 | ||||||||||
| 126232841 | 12623284 | 2 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | UNK UNK, UNKNOWN | U | 0 | |||||||||
| 126232841 | 12623284 | 3 | C | HUMALOG | INSULIN LISPRO | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 126232841 | 12623284 | 4 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 126232841 | 12623284 | 5 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 126232841 | 12623284 | 6 | C | COLCHICINE. | COLCHICINE | 1 | Unknown | UNK, UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126232841 | 12623284 | 1 | Ductal adenocarcinoma of pancreas |
| 126232841 | 12623284 | 2 | Ductal adenocarcinoma of pancreas |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126232841 | 12623284 | HO |
| 126232841 | 12623284 | LT |
| 126232841 | 12623284 | OT |
| 126232841 | 12623284 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126232841 | 12623284 | Anaphylactic reaction | |
| 126232841 | 12623284 | Aspartate aminotransferase increased | |
| 126232841 | 12623284 | Asthenia | |
| 126232841 | 12623284 | Gamma-glutamyltransferase increased | |
| 126232841 | 12623284 | Petechiae | |
| 126232841 | 12623284 | Posterior reversible encephalopathy syndrome | |
| 126232841 | 12623284 | Reversible cerebral vasoconstriction syndrome | |
| 126232841 | 12623284 | Thrombotic microangiopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126232841 | 12623284 | 1 | 201602 | 20160613 | 0 | |
| 126232841 | 12623284 | 2 | 20160711 | 20160711 | 0 |